Phase 4 PALADIN Study with ILUVIEN® Published in Peer-Reviewed Journal Ophthalmology Best corrected visual acuity and central subfield thickness were significantly improved at 36 monthsILUVIEN treatment resulted in a 70.5% reduction in treatment burdenResults confirm that use of prior...